- 24/7 Wall St.•yesterday
Major pharmaceuticals have been under fire in light of the recent Mylan EpiPen pricing fiasco, but now a key research firm is seeing one of these companies in a positive light.
AstraZeneca plc (ADR) (NYSE: AZN ) shares are currently trading at a discount to S&P 500 pharma companies. Argus’ John Eade believes the discount is too steep given the company’s pipeline potential. Eade ...
AstraZeneca PLC (AZN.L)
LSE - LSE Delayed Price. Currency in GBp
|Bid||4,890.00 x 20700|
|Ask||5,100.00 x 15300|
|Day's Range||4,962.00 - 5,109.63|
|52wk Range||3,680.00 - 5,505.00|
|1y Target Est||N/A|
|P/E Ratio (ttm)||28.58|
|Avg Vol (3m)||2,817,303|
|Dividend & Yield||N/A (N/A)|